Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Impact of pharmacological agents on mitochondrial function: a growing opportunity?

Stoker ML, Newport E, Hulit JC, West AP, Morten KJ.

Biochem Soc Trans. 2019 Nov 7. pii: BST20190280. doi: 10.1042/BST20190280. [Epub ahead of print]

PMID:
31696924
2.

The influence of local market and household factors on aflatoxin presence in maize and symptoms of its exposure to children in Guatemala.

Voth-Gaeddert LE, Stoker M, Torres OR, Oerther DB.

Int J Environ Health Res. 2019 Mar 22:1-15. doi: 10.1080/09603123.2019.1594721. [Epub ahead of print]

PMID:
30897935
3.

Association of aflatoxin exposure and height-for-age among young children in Guatemala.

Voth-Gaeddert LE, Stoker M, Torres O, Oerther DB.

Int J Environ Health Res. 2018 Jun;28(3):280-292. doi: 10.1080/09603123.2018.1468424. Epub 2018 Apr 28.

PMID:
29706087
4.

What causes childhood stunting among children of San Vicente, Guatemala: Employing complimentary, system-analysis approaches.

Voth-Gaeddert LE, Stoker M, Cornell D, Oerther DB.

Int J Hyg Environ Health. 2018 Apr;221(3):391-399. doi: 10.1016/j.ijheh.2018.01.001. Epub 2018 Jan 5.

PMID:
29325698
5.

Capsaicin 8% Patch Repeat Treatment in Nondiabetic Peripheral Neuropathic Pain: A 52-Week, Open-Label, Single-Arm, Safety Study.

Gálvez R, Navez ML, Moyle G, Maihöfner C, Stoker M, Ernault E, Nurmikko TJ, Attal N.

Clin J Pain. 2017 Oct;33(10):921-931. doi: 10.1097/AJP.0000000000000473.

PMID:
28872473
6.

Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-analysis.

van Nooten F, Treur M, Pantiri K, Stoker M, Charokopou M.

Clin Ther. 2017 Apr;39(4):787-803.e18. doi: 10.1016/j.clinthera.2017.02.010. Epub 2017 Mar 30. Review.

7.

Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study.

Vinik AI, Perrot S, Vinik EJ, Pazdera L, Jacobs H, Stoker M, Long SK, Snijder RJ, van der Stoep M, Ortega E, Katz N.

BMC Neurol. 2016 Dec 6;16(1):251.

8.

Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study.

Simpson DM, Robinson-Papp J, Van J, Stoker M, Jacobs H, Snijder RJ, Schregardus DS, Long SK, Lambourg B, Katz N.

J Pain. 2017 Jan;18(1):42-53. doi: 10.1016/j.jpain.2016.09.008. Epub 2016 Oct 13.

9.

The Ethics of a Postmortem Testicular Harvest.

Stoker M, Landry A.

J Emerg Med. 2016 Jan;50(1):178-80. doi: 10.1016/j.jemermed.2015.09.020. Epub 2015 Oct 26.

PMID:
26514307
10.

Humanistic and economic burden of painful diabetic peripheral neuropathy in Europe: A review of the literature.

Alleman CJ, Westerhout KY, Hensen M, Chambers C, Stoker M, Long S, van Nooten FE.

Diabetes Res Clin Pract. 2015 Aug;109(2):215-25. doi: 10.1016/j.diabres.2015.04.031. Epub 2015 May 6. Review.

11.

Predictors of Response in Patients With Postherpetic Neuralgia and HIV-Associated Neuropathy Treated With the 8% Capsaicin Patch (Qutenza).

Katz NP, Mou J, Paillard FC, Turnbull B, Trudeau J, Stoker M.

Clin J Pain. 2015 Oct;31(10):859-66. doi: 10.1097/AJP.0000000000000186.

PMID:
25503598
12.

Evidence-based fluid optimisation?

Stevenson S, Stoker M.

Anaesthesia. 2014 Jul;69(7):788-9. doi: 10.1111/anae.12742. No abstract available.

13.

Decreased Rate of CSF Leakage Associated with Complete Reconstruction of Suboccipital Cranial Defects.

Stoker MA, Forbes JA, Hanif R, Cooper C, Nian H, Konrad PE, Neimat JS.

J Neurol Surg B Skull Base. 2012 Aug;73(4):281-6. doi: 10.1055/s-0032-1312709.

14.

Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients.

Mou J, Paillard F, Turnbull B, Trudeau J, Stoker M, Katz NP.

Clin J Pain. 2014 Apr;30(4):286-94. doi: 10.1097/AJP.0b013e31829a4ced.

PMID:
23765045
15.

Efficacy of Qutenza® (capsaicin) 8% patch for neuropathic pain: a meta-analysis of the Qutenza Clinical Trials Database.

Mou J, Paillard F, Turnbull B, Trudeau J, Stoker M, Katz NP.

Pain. 2013 Sep;154(9):1632-9. doi: 10.1016/j.pain.2013.04.044. Epub 2013 May 21.

PMID:
23707278
16.

A novel approach to identify responder subgroups and predictors of response to low- and high-dose capsaicin patches in postherpetic neuralgia.

Martini CH, Yassen A, Krebs-Brown A, Passier P, Stoker M, Olofsen E, Dahan A.

Eur J Pain. 2013 Nov;17(10):1491-501. doi: 10.1002/j.1532-2149.2013.00329.x. Epub 2013 May 6.

PMID:
23650124
17.

Are treatment benefits in neuropathic pain reflected in the Self Assessment of Treatment questionnaire?

Wiklund I, Holmstrom S, Stoker M, Wyrwich KW, Devine M.

Health Qual Life Outcomes. 2013 Jan 18;11:8. doi: 10.1186/1477-7525-11-8.

18.

Validation of the Self-Assessment of Treatment Questionnaire among Patients with Postherpetic Neuralgia.

Wyrwich KW, Kawata AK, Thompson C, Holmstrom S, Stoker M, Wiklund I.

Pain Res Treat. 2012;2012:621619. doi: 10.1155/2012/621619. Epub 2012 Aug 13.

19.

Prior cholecystectomy as a predictor of preoperative vitamin D deficiency in adults undergoing spine surgery.

Stoker GE, Buchowski JM, Stoker ME.

Arch Surg. 2012 Jun;147(6):577-8. doi: 10.1001/archsurg.2012.463. No abstract available.

PMID:
22786550
20.

Pharmacodynamic analysis of the analgesic effect of capsaicin 8% patch (Qutenza™) in diabetic neuropathic pain patients: detection of distinct response groups.

Martini C, Yassen A, Olofsen E, Passier P, Stoker M, Dahan A.

J Pain Res. 2012;5:51-9. doi: 10.2147/JPR.S30406. Epub 2012 Mar 15.

21.

Safety and efficacy of esreboxetine in patients with fibromyalgia: An 8-week, multicenter, randomized, double-blind, placebo-controlled study.

Arnold LM, Chatamra K, Hirsch I, Stoker M.

Clin Ther. 2010 Aug;32(9):1618-32. doi: 10.1016/j.clinthera.2010.08.003.

PMID:
20974319
22.

Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial.

van Seventer R, Feister HA, Young JP Jr, Stoker M, Versavel M, Rigaudy L.

Curr Med Res Opin. 2006 Feb;22(2):375-84.

PMID:
16466610
23.

Cardiovascular consequences of the concomitant administration of nifedipine and magnesium sulfate in pigs.

Stoker M, Munday I.

Int J Obstet Anesth. 1999 Apr;8(2):145-6. No abstract available.

PMID:
15321165
24.

A G2/M cell cycle block in transformed cells by contact with normal neighbors.

Allard D, Stoker M, Gherardi E.

Cell Cycle. 2003 Sep-Oct;2(5):484-7.

PMID:
12963849
25.

Effectiveness and long-term results of laparoscopic common bile duct exploration.

Riciardi R, Islam S, Canete JJ, Arcand PL, Stoker ME.

Surg Endosc. 2003 Jan;17(1):19-22. Epub 2002 Oct 29.

PMID:
12399840
26.

Protective effects of inhibiting both blood and vascular selectins after stroke and reperfusion.

Ruehl ML, Orozco JA, Stoker MB, McDonagh PF, Coull BM, Ritter LS.

Neurol Res. 2002 Apr;24(3):226-32.

PMID:
11958413
27.

Laparoscopic repair of postoperative perineal hernia.

Ghellai AM, Islam S, Stoker ME.

Surg Laparosc Endosc Percutan Tech. 2002 Apr;12(2):119-21.

PMID:
11948300
28.

Schistosomiasis at Christchurch Hospital, 1989-94.

McKenna G, Lyttle H, Withington S, Stoker M, Morton A, Paltridge G, Murdoch D, Chambers ST.

Aust N Z J Med. 1996 Apr;26(2):226-7. No abstract available.

PMID:
8744622
29.

Fundamentals of cancer cell biology.

Stoker M.

Adv Cancer Res. 1996;70:1-19. Review. No abstract available.

PMID:
8902051
30.

HGF/SF inhibits junctional communication.

Moorby CD, Stoker M, Gherardi E.

Exp Cell Res. 1995 Aug;219(2):657-63.

PMID:
7641817
31.

Laparoscopic adrenal surgery.

Stoker ME, Patwardhan N, Maini BS.

Surg Endosc. 1995 Apr;9(4):387-90; discussion 391.

PMID:
7660259
32.

Common bile duct exploration in the era of laparoscopic surgery.

Stoker ME.

Arch Surg. 1995 Mar;130(3):265-8; discussion 268-9.

PMID:
7887793
33.

Laparoscopic colon surgery for cancer: controversy, caution and common sense.

Stoker ME.

Int Surg. 1994 Jul-Sep;79(3):240-1. No abstract available.

PMID:
7883504
34.

Hepatocyte growth factor/scatter factor (HGF/SF), the c-met receptor and the behaviour of epithelial cells.

Gherardi E, Sharpe M, Lane K, Sirulnik A, Stoker M.

Symp Soc Exp Biol. 1993;47:163-81. Review.

PMID:
8165564
35.
36.

Paroxetine in the treatment of melancholia and severe depression.

Tignol J, Stoker MJ, Dunbar GC.

Int Clin Psychopharmacol. 1992 Nov;7(2):91-4.

PMID:
1487627
37.

Laparoscopic cholecystectomy. A clinical and financial analysis of 280 operations.

Stoker ME, Vose J, O'Mara P, Maini BS.

Arch Surg. 1992 May;127(5):589-94; discussion 594-5.

PMID:
1533508
38.

Down-regulation of scatter factor in MRC 5 fibroblasts by epithelial-derived cells. A model for scatter factor modulation.

Kamalati T, Thirunavukarasu B, Wallace A, Holder N, Brooks R, Nakamura T, Stoker M, Gherardi E, Buluwela L.

J Cell Sci. 1992 Feb;101 ( Pt 2):323-32.

39.

Laparoscopic common bile duct exploration.

Stoker ME, Leveillee RJ, McCann JC Jr, Maini BS.

J Laparoendosc Surg. 1991 Oct;1(5):287-93.

PMID:
1834281
40.

Hepatocyte growth factor--scatter factor: mitogen, motogen, and met.

Gherardi E, Stoker M.

Cancer Cells. 1991 Jun;3(6):227-32. Review. No abstract available.

PMID:
1832923
41.

Regulation of cell movement: the motogenic cytokines.

Stoker M, Gherardi E.

Biochim Biophys Acta. 1991 Apr 16;1072(1):81-102. Review. No abstract available.

PMID:
2018780
42.

Epithelial scatter factor and development of the chick embryonic axis.

Stern CD, Ireland GW, Herrick SE, Gherardi E, Gray J, Perryman M, Stoker M.

Development. 1990 Dec;110(4):1271-84.

43.

Hepatocytes and scatter factor.

Gherardi E, Stoker M.

Nature. 1990 Jul 19;346(6281):228. No abstract available.

PMID:
2142751
44.

Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement.

Gherardi E, Gray J, Stoker M, Perryman M, Furlong R.

Proc Natl Acad Sci U S A. 1989 Aug;86(15):5844-8.

45.

Effect of scatter factor on motility of epithelial cells and fibroblasts.

Stoker M.

J Cell Physiol. 1989 Jun;139(3):565-9.

PMID:
2525565
46.

Scatter factor and other regulators of cell mobility.

Stoker M, Gherardi E.

Br Med Bull. 1989 Apr;45(2):481-91. Review.

PMID:
2532052
47.

Split skin grafting using topical local anaesthesia (EMLA): a comparison with infiltrated anaesthesia.

Goodacre TE, Sanders R, Watts DA, Stoker M.

Br J Plast Surg. 1988 Sep;41(5):533-8.

PMID:
3052675
48.

Scatter factor is a fibroblast-derived modulator of epithelial cell mobility.

Stoker M, Gherardi E, Perryman M, Gray J.

Nature. 1987 May 21-27;327(6119):239-42.

PMID:
2952888
49.

Factors affecting epithelial interactions.

Stoker M, Gherardi E.

Ciba Found Symp. 1987;125:217-39.

PMID:
3829836
50.

Dipstick analysis for screening of paediatric urine.

Boreland PC, Stoker M.

J Clin Pathol. 1986 Dec;39(12):1360-2. No abstract available.

Supplemental Content

Loading ...
Support Center